Floatz logo

Folic Acid

Hypertensive Disorder

Shenzhen Ausa Pharmed Co.,LtdSmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
81/ 100

Competitive context

32 Active assets in the Hypertensive Disorder cohort.

Asset / SponsorPhaseRating
Hydrochlorothiazide
University of Kansas Medical Center
Phase 4BBB
VALSARTAN
University of Alabama at Birmingham
Phase 4BBB
AMLODIPINE
Jing Liu
Phase 4BBB
Losartan
Rong Zhang
Phase 4BBB
Trandolapril
University of Florida
Phase 4BBB

View all 50 →

Same molecule, other indications

Folic Acid is also rated in:

hyperhomocysteinemiaActive
BBB
Indicative · Phase 4
76 / 100
View asset →
myocardial infarctionDormant
BBB
Indicative · Phase 4
72 / 100
View asset →
polycystic ovary syndromeActive
BB
Indicative · Phase 4
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →